Background: Metabolic syndrome (MetS) is a combination of complex group of cardiovascular risk factors, which include central adiposity, high blood pressure, dyslipidaemia and elevated fasting blood glucose. Generally, the prevalence of MetS in diabetes patients is high and the syndrome tends to promote the development of diabetes and other chronic diseases. Diabetes is characterised by high random plasma glucose as well as polyuria, polydipsia and weight loss etc. Aim: This study aims to determine the prevalence of MetS in diabetics’ patients using the National Cholesterol Education Programme (NCEP) ATP III criteria, World Health Organisation and International Diabetes Federation definitions in quantifying the syndrome. Method: This cross-sectional study involved 103 diabetes patients in the Cape Coast Metropolis, Central Region. Anthropometric measurements and fasting blood samples for blood sugar and lipids were taken. Blood pressures were recorded from their personal health record files. The NCEP ATP III, WHO and IDF criteria were used to define diabetes patients with the metabolic syndrome. Results: A total of 42 (40.8%), 31(30.1%), 81 (78.6%) were obese, overweight and have high waist circumference (IDF) respectively. Also all the participants had a low high density lipoprotein (HDL) level with 42(95.5%) having high triglycerides (TG). Significant associations were found for age range of 66-75(OR= 16.00, CI= 1.32-194.62), women (OR= 14.06; CI= 2.50-79.05) and high blood pressure (OR= 5.83, CI= 1.22-39.93). Prevalence of MetS was 38.60%, 59.09% and 75.00% using WHO, NCEP ATP III and IDF criteria respectively. Conclusion: A high prevalence of MetS was observed among the diabetes patients. The prevalence among the females was higher than that of the males.
| Published in | Journal of Food and Nutrition Sciences (Volume 5, Issue 2) |
| DOI | 10.11648/j.jfns.20170502.13 |
| Page(s) | 34-43 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Diabetes, Metabolic Syndrome, Dyslipidaemia, Central Obesity, High Blood Pressure
| [1] | R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome” Lancet, vol. 365, no. 9468, pp.1415-1428, 2005. |
| [2] | M. P. Stern, K. Williams, C. González-Villalpando, K. J. Hunt, and S. M. Haffner, “Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?” Diabetes Care, vol. 27, no. 11, pp. 2676-2681, 2004. |
| [3] | G. Marchesini, G. Forlani, F. Cerrelli, R. Manini, S. Natale, L. Baraldi, G. Ermini, G. Savaroni, D. Zocchi, and N. Melchionda, “WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes”, Diabetic Medicine, vol. 21, no.4, pp. 383-387, 2004. |
| [4] | M. Gyakobo, A. G. B. Amoah, D. A. Martey-Marbell, and R. C. Snow, Prevalence of the metabolic syndrome in a rural population in Ghana” BMC Endocrine Disorders, vol. 12 p.25, 2012. |
| [5] | J. Akpalu, A. Akpalu, and F. Offei, “The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana”, Ghana Medical Journal, vol. 45, no.4, pp.161-166, 2011. |
| [6] | S. Mottillo, K. B. Filion, J. Genest, L. Joseph, L. Pilote, P. Poirier, S. Rinfret, E. L. Schiffrin, and M. J. Einsenberg, “The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis”, Journal of American College of Cardiology, vol. 56, no.14, pp.1113-1132, 2010. |
| [7] | E. S. Ford, C. Li, and N. Sattar, “Metabolic syndrome and incident diabetes: current state of the evidence,” Diabetes Care, vol. 31, no. 9, pp. 1898-1904, 2008. |
| [8] | K. Esposito, P. Chiodini, A. Colao, A. Lenzi, and D. Giugliano, “Metabolic syndrome and risk of cancer: a systematic review and meta-analysis”, Diabetes Care vol. 35, no. 11, pp.2402-2411, 2012. |
| [9] | J. Chen, P. Muntner, L. L. Hamm, D. W. Jones, V. Batuman, V. Fonseca, P. K. Whelton, and J He, “The metabolic syndrome and chronic kidney disease in US adults detected by the National Diabetes Data group or the Carpenter and Coustan plasma glucose, “ Annals of Internal Medicine, vol. 140, no. 3, pp. 167-174, 2004. |
| [10] | E. Bonora, G. Targher, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, L. Gemma, L. Santi, R. C. Bonadonna and M. Muggeo, “The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects Prospective data from the Verona Diabetes Complications Study”, Journal of Diabetic Medicine, vol. 21, no. 1, pp. 52-58, 2004. |
| [11] | A. J. Cameron, J. E. Shaw, and P. Z. Zimmet, “The metabolic syndrome: prevalence in world-wide populations”, Journal of Endocrinology Metabolism Clinics of North America, vol. 33, no. 2, pp. 351-375, 2004. |
| [12] | D. J. Magliano, A. Cameron, J. E. Shaw, and P. Z. Zimmet, “Epidemiology of metabolic syndrome. In: Ekoé JM, Rewers M, Williams R, Zimmet P, editors. Epidemiology of diabetes mellitus. 2nd ed. Chichester (UK): Wiley-Blackwell 31-49, 2008. |
| [13] | S. M. Grundy, “Metabolic syndrome: a multiplex cardiovascular risk factor”, Journal of Clinical Endocrinology and Metabolism vol. 92, no. 2, pp. 399-404, 2007. |
| [14] | M. P. Stern, K. Williams, C. González-Villalpando, K. J. Hunt, and S. M. Haffner, “Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?”, Diabetes Care, vol. 27, no. 11, pp. 2676-2681, 2004. |
| [15] | K. Lundback, “Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus”, 3v Med J vol.1, no. 5291, pp. 1507-1513, 1962. |
| [16] | N. Amidu, W. K, B. A. Owiredu, H. Alidu, C. Sarpong, and C. K. Gyasi Sarpong, “Association between metabolic syndrome and sexual dysfunction among men with clinically diagnosed diabete”. Journal of Diabetology and Metabolic Syndrome, vol. 5, p. 42, 2013. |
| [17] | WHO, “Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization, 1995. |
| [18] | N. W. Tietz, “Fundamentals of Clinical Chemistry,” Saunders Inc., Philadelphia, PA, p. 329, 1970. |
| [19] | K. G. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome – a new world wide definition” Lancet, vol. 366, no. 9491, pp.1059-1062, 2005. |
| [20] | Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP), “Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)”, Journal of American Medical Association, vol. 285 pp. 2486-2497, 2001. |
| [21] | K. G. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome -a new world-wide definition. A Consensus Statement from the International Diabetes Federation”, 2006. |
| [22] | A. P. Kengne, S. N. Limen, E. Sobngwi, C. F. T. Djouogo, and C. Nouedoui, Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan African”, Diabetology and Metabolic Syndrome, vol. 4, no. 1, pp. 22-22, 2012. |
| [23] | S. Isezuo, and E. Ezunu, “Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients”, Journal of National Medical Association, vol. 97, no. 5, pp. 557–563, 2005. |
| [24] | C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, “NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older”, Diabetes, vol. 52, no.5 pp. 1210-1214, 2003. |
| [25] | F. V. K. Titty, W. K. B. A. Owiredu, and M. T. Agyei Frempong, “Prevalence of MetS and its individual components among Diabetic patients in Ghana”, Journal of Biological Science, vol. 8, pp. 1057-1061, 2008. |
| [26] | S. P. Surana, D. B. Shah, K. Gala, S. Susheja, S. S. Hoskote, N. Gill, S. R. Joshi, and V. Panikar, 2008, Prevalence of Metabolic Syndrome in an Urban Indian Diabetic Population using The NCEP ATP III Guidelines, Journal of Assocation of Physicians in India, 56 865-868. |
| [27] | C. O. Alebiosu, and B. O. Odusan, “Metabolic syndrome in subjects with type-2 diabetes mellitus”. Journal of National Medical Association, vol. 96, no. 6, pp. 817-821, 2004. |
| [28] | A. S. Leon, and O. A. Sanchez, “Response of blood lipids to exercise training alone or combined with dietary intervention”, Medicine and Science in Sports and Exercises vol.33, no. 6, pp. S502-15; discussion S528-9., 2001. |
| [29] | A. K. Ahmed, T. E. Yasmeen, T. S. Awan, and N. Islam, “Metabolic syndrome in type 2 diabetes: Comparison of WHO, modified ATP III and IDF criteria”, Journal of Pakistan Medical Assocation, vol.62, no.6, pp. 569-574, 2012. |
| [30] | A. O. Ogbera, “Prevalence and gender distribution of the metabolic syndrome”, Diabetology and Metabolic Syndrome, vol. 2, no. 1, pp. 4, 2010. |
| [31] | R. Raman, A. Gupta, S. S. Pal, S. Ganesan, K. Venkatesh, V. Kulothungan, T. Sharma, “Prevalence of metabolic syndrome and its influence on microvascular complications in the Indian population with type 2 diabetes mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 14)”, Diabetology and Metabolic Syndrome, vol. 2, no. 67, pp. 1-9, 2010. |
| [32] | E. Dhanaraj, A. Bhansali, S. Jaggi, P. Dutra, S. Jain, P. Tiwari, P. Ramarao, “Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus”,Journal of Indian Medical Association vol. 106, no. 6, pp. 366-368, 370 -372, 2008. |
| [33] | S. M. Grundy, H. B., Jr. Brewer, J. I. Cleeman, S. C., Jr. Smith, and C. Lenfant, “Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to Circulation”, vol.109, no. 3, pp. 433-438, 2004. |
| [34] | L. Fezeu, B. Balkau, A. P. Kengne, E. Sobngwi, and J. C. Mbanya, “Metabolic syndrome in a sub-Saharan African setting: central obesity may be the the key determinant”, Atherosclerosis vol. 193, no. 1, pp. 70-76, 2007. |
| [35] | E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey”, Journal of the American Medical Association, vol. 287, no. 3, pp. 356-379, 2002. |
| [36] | G. T. Ko, C. S. Cockram, C. C. Chow, V. Yeung, W. B. Chan, W. Y. So, N. N. Chan, and J. C. Chan, “High prevalence of metabolic syndrome in Hong Kong Chinese--comparison of three diagnostic criteria”, Diabetes Research and Clinical Practice vol. 69, no. 2, pp. 160-168, 2005. |
| [37] | M. M. Fahlman, D. Boardley, C. P. Lambert, and M. G. Flynn, “Effects of endurance training and resistance training on plasma lipoprotein profiles in elderly women”, Journal of Gerontology series A Biological Sciences Medical-Science vol. 57, no.2, pp. B54-B60, 2002. |
| [38] | W. E. Kraus, J. A. Houmard, B. D. Duscha, K. J. Knetzger, M. B. Wharton, J. S. McCartney, C. W. Bales, S. Henes, G. P. Samsa, J. D. Otvos, and K. R. Kulkarni, “Effects of the amount and intensity of exercise on plasma lipoproteins”, New England Journal of Medicine, vol. 347, no. 19, pp. 1483-1492, 2002. |
| [39] | L. Byberg, B. Zethelius, P. M. McKeigue, and H. O. Lithell, “Changes in physical activity are associated with changes in metabolic cardiovascular risk factors”, Diabetologia,vol. 44, no. 12, pp. 2134-2139, 2001. |
| [40] | P. J. Arciero, M. D. Vukovich, J. O. Holloszy, S. B. Racette, and W. M. Kohrt, “Comparison of short-term diet and exercise on insulin action in individuals with abnormal glucose tolerance” Journal of Applied Physiology vol. 86, no. 6, pp. 930-1935, 1999. |
| [41] | M. L. Irwin, E. J. Mayer-Davis, C. L. Addy, R. R. Pate, J. L. Durstine, L. M. Stolarczyk, and B. E. Ainsworth, “Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study”, Journal of Diabetes Care, vol. 23, no. 2, pp. 449-454, 2000. |
| [42] | F. B. Hu, M. F. Leitzmann, M. J. Stampfer, G. A. Colditz, W. C. Willett, and E. B. Rimm, “Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men”, Journal of Archives Internal Medicine, vol. 161, no. 12, pp. 1542-1548, 2001. |
| [43] | E. S. Ford, H. G. Wayne, and H. M. Ali. "Increasing prevalence of the metabolic syndrome among US adults," Diabetes care, vol. 27, no. 10, pp. 2444-2449, 2004. |
| [44] | R. R. Dalacorte, C. L. Reichert, and J. L. Vieira, “Metabolic syndrome and physical activity in southern Brazilian community-dwelling elders: a population based, cross-sectional study”, BioMed Central Public Health, vol.25, no. 9, pp. 1471-2458, 2009. |
| [45] | C. E. Tudor-Locke, and A. M. Myers, “Challenges and opportunities for measuring physical activity in sedentary adults”, Sports Medicine, vol. 31, no.2, pp. 91-100, 2001. |
| [46] | J. A. Heady, J. N. Morris, and P. A. Raffle, “Physique of London busmen; epidemiology of uniforms”, Lancet, vol. 271, no. 6942, pp.569-570, 1956. |
| [47] | J. Ekezie, S. S. Adebisi, and B. Danborno, “The Effect of Marital Status and Self-Reported Physical Exercise on the Adiposity and Blood Pressure of the Igbos of Nigeria”, Internet Journal of Medical Update, vol.4, no. 1, pp. 7-14, 2009. |
APA Style
Heckel Amoabeng Abban, Precious Barnes, Du-Bois Asante, Emmanuel Effah-Yeboah, Paul Nsiah, et al. (2017). Prevalence of Metabolic Syndrome Among Diabetes Patients in Central Regional Hospital, Cape Coast, Ghana. Journal of Food and Nutrition Sciences, 5(2), 34-43. https://doi.org/10.11648/j.jfns.20170502.13
ACS Style
Heckel Amoabeng Abban; Precious Barnes; Du-Bois Asante; Emmanuel Effah-Yeboah; Paul Nsiah, et al. Prevalence of Metabolic Syndrome Among Diabetes Patients in Central Regional Hospital, Cape Coast, Ghana. J. Food Nutr. Sci. 2017, 5(2), 34-43. doi: 10.11648/j.jfns.20170502.13
AMA Style
Heckel Amoabeng Abban, Precious Barnes, Du-Bois Asante, Emmanuel Effah-Yeboah, Paul Nsiah, et al. Prevalence of Metabolic Syndrome Among Diabetes Patients in Central Regional Hospital, Cape Coast, Ghana. J Food Nutr Sci. 2017;5(2):34-43. doi: 10.11648/j.jfns.20170502.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jfns.20170502.13,
author = {Heckel Amoabeng Abban and Precious Barnes and Du-Bois Asante and Emmanuel Effah-Yeboah and Paul Nsiah and Shadrack Fenuku},
title = {Prevalence of Metabolic Syndrome Among Diabetes Patients in Central Regional Hospital, Cape Coast, Ghana},
journal = {Journal of Food and Nutrition Sciences},
volume = {5},
number = {2},
pages = {34-43},
doi = {10.11648/j.jfns.20170502.13},
url = {https://doi.org/10.11648/j.jfns.20170502.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jfns.20170502.13},
abstract = {Background: Metabolic syndrome (MetS) is a combination of complex group of cardiovascular risk factors, which include central adiposity, high blood pressure, dyslipidaemia and elevated fasting blood glucose. Generally, the prevalence of MetS in diabetes patients is high and the syndrome tends to promote the development of diabetes and other chronic diseases. Diabetes is characterised by high random plasma glucose as well as polyuria, polydipsia and weight loss etc. Aim: This study aims to determine the prevalence of MetS in diabetics’ patients using the National Cholesterol Education Programme (NCEP) ATP III criteria, World Health Organisation and International Diabetes Federation definitions in quantifying the syndrome. Method: This cross-sectional study involved 103 diabetes patients in the Cape Coast Metropolis, Central Region. Anthropometric measurements and fasting blood samples for blood sugar and lipids were taken. Blood pressures were recorded from their personal health record files. The NCEP ATP III, WHO and IDF criteria were used to define diabetes patients with the metabolic syndrome. Results: A total of 42 (40.8%), 31(30.1%), 81 (78.6%) were obese, overweight and have high waist circumference (IDF) respectively. Also all the participants had a low high density lipoprotein (HDL) level with 42(95.5%) having high triglycerides (TG). Significant associations were found for age range of 66-75(OR= 16.00, CI= 1.32-194.62), women (OR= 14.06; CI= 2.50-79.05) and high blood pressure (OR= 5.83, CI= 1.22-39.93). Prevalence of MetS was 38.60%, 59.09% and 75.00% using WHO, NCEP ATP III and IDF criteria respectively. Conclusion: A high prevalence of MetS was observed among the diabetes patients. The prevalence among the females was higher than that of the males.},
year = {2017}
}
TY - JOUR T1 - Prevalence of Metabolic Syndrome Among Diabetes Patients in Central Regional Hospital, Cape Coast, Ghana AU - Heckel Amoabeng Abban AU - Precious Barnes AU - Du-Bois Asante AU - Emmanuel Effah-Yeboah AU - Paul Nsiah AU - Shadrack Fenuku Y1 - 2017/03/18 PY - 2017 N1 - https://doi.org/10.11648/j.jfns.20170502.13 DO - 10.11648/j.jfns.20170502.13 T2 - Journal of Food and Nutrition Sciences JF - Journal of Food and Nutrition Sciences JO - Journal of Food and Nutrition Sciences SP - 34 EP - 43 PB - Science Publishing Group SN - 2330-7293 UR - https://doi.org/10.11648/j.jfns.20170502.13 AB - Background: Metabolic syndrome (MetS) is a combination of complex group of cardiovascular risk factors, which include central adiposity, high blood pressure, dyslipidaemia and elevated fasting blood glucose. Generally, the prevalence of MetS in diabetes patients is high and the syndrome tends to promote the development of diabetes and other chronic diseases. Diabetes is characterised by high random plasma glucose as well as polyuria, polydipsia and weight loss etc. Aim: This study aims to determine the prevalence of MetS in diabetics’ patients using the National Cholesterol Education Programme (NCEP) ATP III criteria, World Health Organisation and International Diabetes Federation definitions in quantifying the syndrome. Method: This cross-sectional study involved 103 diabetes patients in the Cape Coast Metropolis, Central Region. Anthropometric measurements and fasting blood samples for blood sugar and lipids were taken. Blood pressures were recorded from their personal health record files. The NCEP ATP III, WHO and IDF criteria were used to define diabetes patients with the metabolic syndrome. Results: A total of 42 (40.8%), 31(30.1%), 81 (78.6%) were obese, overweight and have high waist circumference (IDF) respectively. Also all the participants had a low high density lipoprotein (HDL) level with 42(95.5%) having high triglycerides (TG). Significant associations were found for age range of 66-75(OR= 16.00, CI= 1.32-194.62), women (OR= 14.06; CI= 2.50-79.05) and high blood pressure (OR= 5.83, CI= 1.22-39.93). Prevalence of MetS was 38.60%, 59.09% and 75.00% using WHO, NCEP ATP III and IDF criteria respectively. Conclusion: A high prevalence of MetS was observed among the diabetes patients. The prevalence among the females was higher than that of the males. VL - 5 IS - 2 ER -
Email: